Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 15,028 |
|
|||||
| News | - | ||||||
| Day High | 0.3949 | Low High |
|||||
| Day Low | 0.367 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0185 | -4.71% | 0.374 | 10:59:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3949 | 0.367 | 0.3949 | 0.3925 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 49 | 15,028 | $ 0.376791 | $ 5,662 | - | 0.26 - 7.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:30:02 | 1 | $ 0.3938 | USD |
Galmed Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 621.6k | 1.68M | - | 0 | -6.91M | -4.11 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Galmed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.378 | 0.40 | 0.35 | 0.3760917 | 47,254 | -0.004 | -1.06% |
| 1 Month | 0.34 | 0.44 | 0.315 | 0.3738174 | 270,987 | 0.034 | 10.00% |
| 3 Months | 0.40 | 0.4688 | 0.30 | 0.3543556 | 218,580 | -0.026 | -6.50% |
| 6 Months | 0.3885 | 0.47 | 0.26 | 0.3714541 | 192,824 | -0.0145 | -3.73% |
| 1 Year | 4.80 | 7.80 | 0.26 | 1.95 | 228,775 | -4.43 | -92.21% |
| 3 Years | 48.45 | 61.20 | 0.26 | 17.37 | 170,326 | -48.08 | -99.23% |
| 5 Years | 123.30 | 127.581 | 0.26 | 35.00 | 154,124 | -122.93 | -99.70% |
Galmed Pharmaceuticals Description
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. |
